237 related articles for article (PubMed ID: 34791715)
1. Immunohistochemical and immunofluorescence expression profile of lymphatic endothelial cell markers in oral cancer.
Chutipongpisit K; Parachuru VP; Friedlander LT; Hussaini HM; Rich AM
Int J Exp Pathol; 2021 Dec; 102(6):268-278. PubMed ID: 34791715
[TBL] [Abstract][Full Text] [Related]
2. Lymph vessel density in seminomatous testicular cancer assessed with the specific lymphatic endothelium cell markers D2-40 and LYVE-1: correlation with pathologic parameters and clinical outcome.
Heinzelbecker J; Kempf KM; Kurz K; Steidler A; Weiss C; Jackson DG; Bolenz C; Haecker A; Trojan L
Urol Oncol; 2013 Oct; 31(7):1386-94. PubMed ID: 21974896
[TBL] [Abstract][Full Text] [Related]
3. The lymphatic system in clinically localized urothelial carcinoma of the bladder: morphologic characteristics and predictive value.
Bolenz C; Auer M; Ströbel P; Heinzelbecker J; Schubert C; Trojan L
Urol Oncol; 2013 Nov; 31(8):1606-14. PubMed ID: 22503575
[TBL] [Abstract][Full Text] [Related]
4. The role of novel prognostic markers PROX1 and FOXC2 in carcinogenesis of oral squamous cell carcinoma.
Agnihotri NS; Astekar M
J Exp Ther Oncol; 2018 May; 12(3):171-184. PubMed ID: 29790306
[TBL] [Abstract][Full Text] [Related]
5. Prox-1 and VEGFR3 antibodies are superior to D2-40 in identifying endothelial cells of lymphatic malformations--a proposal of a new immunohistochemical panel to differentiate lymphatic from other vascular malformations.
Castro EC; Galambos C
Pediatr Dev Pathol; 2009; 12(3):187-94. PubMed ID: 18937526
[TBL] [Abstract][Full Text] [Related]
6. The potential lymphangiogenic effects of hepatocyte growth factor/scatter factor in vitro and in vivo.
Jiang WG; Davies G; Martin TA; Parr C; Watkins G; Mansel RE; Mason MD
Int J Mol Med; 2005 Oct; 16(4):723-8. PubMed ID: 16142411
[TBL] [Abstract][Full Text] [Related]
7. Co-expression of vascular and lymphatic endothelial cell markers on early endothelial cells present in aspirated coronary thrombi from patients with ST-elevation myocardial infarction.
Rakocevic J; Kojic S; Orlic D; Stankovic G; Ostojic M; Petrovic O; Zaletel I; Puskas N; Todorovic V; Labudovic-Borovic M
Exp Mol Pathol; 2016 Feb; 100(1):31-8. PubMed ID: 26657000
[TBL] [Abstract][Full Text] [Related]
8. Transient Expression of Lymphatic Markers in Retrobulbar Intraconal Orbital Vasculature During Fetal Development.
van den Bosch QCC; van Beek JGM; Kiliç E; Verdijk RM
Invest Ophthalmol Vis Sci; 2020 Jun; 61(6):22. PubMed ID: 32516408
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of lymphatic vessel density in oral squamous cell carcinoma.
Chen J; Zhang F; Hua M; Song X; Liu S; Dong Z
Life Sci; 2021 Jan; 265():118746. PubMed ID: 33181177
[TBL] [Abstract][Full Text] [Related]
10. Lymphangiogenesis and Lymph Node Metastasis in Oral Squamous Cell Carcinoma.
Arimoto S; Hasegawa T; Takeda D; Saito I; Amano R; Akashi M; Komori T
Anticancer Res; 2018 Nov; 38(11):6157-6162. PubMed ID: 30396932
[TBL] [Abstract][Full Text] [Related]
11. Detection of lymphangiogenesis in non-small cell lung cancer and its prognostic value.
Sun JG; Wang Y; Chen ZT; Zhuo WL; Zhu B; Liao RX; Zhang SX
J Exp Clin Cancer Res; 2009 Feb; 28(1):21. PubMed ID: 19216806
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
[TBL] [Abstract][Full Text] [Related]
13. Prox 1, VEGF-C and VEGFR3 expression during cervical neoplasia progression as evidence of an early lymphangiogenic switch.
Cimpean AM; Mazuru V; Saptefrati L; Ceausu R; Raica M
Histol Histopathol; 2012 Dec; 27(12):1543-50. PubMed ID: 23059885
[TBL] [Abstract][Full Text] [Related]
14. Investigation of intratumoural and peritumoural lymphatics expressed by podoplanin and LYVE-1 in the hybridoma-induced tumours.
Ji RC; Eshita Y; Kato S
Int J Exp Pathol; 2007 Aug; 88(4):257-70. PubMed ID: 17696907
[TBL] [Abstract][Full Text] [Related]
15. Tumour expression of lymphangiogenic growth factors but not lymphatic vessel density is implicated in human cervical cancer progression.
Sotiropoulou N; Bravou V; Kounelis S; Damaskou V; Papaspirou E; Papadaki H
Pathology; 2010 Dec; 42(7):629-36. PubMed ID: 21080871
[TBL] [Abstract][Full Text] [Related]
16. Relationships between lymphangiogenesis and angiogenesis during inflammation in rat mesentery microvascular networks.
Sweat RS; Stapor PC; Murfee WL
Lymphat Res Biol; 2012 Dec; 10(4):198-207. PubMed ID: 23240958
[TBL] [Abstract][Full Text] [Related]
17. Lymph and blood vessel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1).
Trojan L; Michel MS; Rensch F; Jackson DG; Alken P; Grobholz R
J Urol; 2004 Jul; 172(1):103-7. PubMed ID: 15201747
[TBL] [Abstract][Full Text] [Related]
18. Lymphangiogenesis in COPD: another link in the pathogenesis of the disease.
Hardavella G; Tzortzaki EG; Siozopoulou V; Galanis P; Vlachaki E; Avgousti M; Stefanou D; Siafakas NM
Respir Med; 2012 May; 106(5):687-93. PubMed ID: 22154125
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the diagnostic accuracy of lymphatic endothelium markers: Bayesian approach.
Evangelou E; Kyzas PA; Trikalinos TA
Mod Pathol; 2005 Nov; 18(11):1490-7. PubMed ID: 15990898
[TBL] [Abstract][Full Text] [Related]
20. Markers for microscopic imaging of lymphangiogenesis and angiogenesis.
Baluk P; McDonald DM
Ann N Y Acad Sci; 2008; 1131():1-12. PubMed ID: 18519955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
